Clinical and quality of life impacts of IVIg and SCIg therapy differ in patients with secondary immunodeficiency compared to those with primary immunodeficiency

Abstract

Tanja Windegger, J English, K Morewood, H Weston, Mary Kynn and Yoke Lin Fung

Vox Sanguinis, Vol.114(S1), pp.218-218

Regional Congress of the International Society of Blood Transfusion (ISBT), 29th (Basel, Switzerland, 22-Jun-2019–26-Jun-2019)

2019

Abstract

Clinical Sciences

Medical Physiology

No abstract available.

Title: Clinical and quality of life impacts of IVIg and SCIg therapy differ in patients with secondary immunodeficiency compared to those with primary immunodeficiency
Authors: Tanja Windegger (Author) - University of the Sunshine Coast
J English (Author) - Sunshine Coast Hospital and Health Service
K Morewood (Author) - Sunshine Coast Hospital and Health Service
H Weston (Author) - Sunshine Coast Hospital and Health Service
Mary Kynn (Author) - University of the Sunshine Coast
Yoke Lin Fung (Author) - University of the Sunshine Coast
Publication details: Vox Sanguinis, Vol.114(S1), pp.218-218
Conference details: Regional Congress of the International Society of Blood Transfusion (ISBT), 29th (Basel, Switzerland, 22-Jun-2019–26-Jun-2019)
Publisher: Wiley-Blackwell Publishing Ltd.
Date published: 2019
DOI: 10.1111/vox.12792
ISSN: 0042-9007; 1423-0410; 0042-9007
Organisation Unit: School of Health - Biomedicine; School of Health and Sport Sciences - Legacy; School of Health and Behavioural Sciences - Legacy
Language: English
Record Identifier: 99451470302621
Output Type: Abstract

313 Record Views